Anticoagulation and stress-induced cardiomyopathy Saagar K. SanghviDavid M. Harris ReviewPaper 11 October 2018 Pages: 1 - 7
Elevated lipoprotein(a) as a new risk factor of cerebral venous sinus thrombosis: association with fibrin clot properties Anna Aleksandra SkuzaMaciej PolakAnetta Undas OriginalPaper Open access 03 December 2018 Pages: 8 - 15
A narrative review of the cardiovascular risks associated with concomitant aspirin and NSAID use Paul GurbelUdaya TantrySteven Weisman ReviewPaper 07 November 2018 Pages: 16 - 30
Changes in treatment and outcomes after creation of a pulmonary embolism response team (PERT), a 10-year analysis Rachel RosovskyYuchiao ChangChristopher Kabrhel OriginalPaper 21 September 2018 Pages: 31 - 40
Correction to: Changes in treatment and outcomes after creation of a pulmonary embolism response team (PERT), a 10-year analysis Rachel RosovskyYuchiao ChangChristopher Kabrhel Correction 30 November 2018 Pages: 41 - 41
Real-time surveillance of left atrial appendage thrombus during contrast computed tomography imaging for catheter ablation: THe Reliability of cOMputed tomography Beyond UltraSound in THROMBUS detection (THROMBUS) study Tetsuma KawajiHitomi NumamotoTakeshi Kimura OriginalPaper 24 September 2018 Pages: 42 - 50
Bariatric surgery in morbidly obese individuals affects plasma levels of protein C and thrombomodulin Gersina Rega-KaunChristoph KaunPhilipp J. Hohensinner OriginalPaper Open access 26 September 2018 Pages: 51 - 56
Postoperative bridging anticoagulation and left ventricular assist system thrombosis David M. NemerGarrick C. StewartJean M. Connors OriginalPaper 25 September 2018 Pages: 57 - 66
Interaction between tissue factor pathway inhibitor-2 gene polymorphisms and environmental factors associated with coronary atherosclerosis in a Chinese Han Hairong ZhouYanjuan CheShaopeng Zhang OriginalPaper 20 October 2018 Pages: 67 - 72
Carbon monoxide inhibits the anticoagulant activity of phospholipase A2 purified from Crotalus adamanteus venom Vance G. Nielsen OriginalPaper 29 October 2018 Pages: 73 - 79
Effect of a new inhibitor of factor Xa zifaxaban, on thrombosis in the inferior vena cava in rabbits Xiaomiao QiuJunjun ZhouShuangyong Sun OriginalPaper 08 October 2018 Pages: 80 - 86
Multiplex testing for Factor II and Factor V mutations in thrombophilia: technical verification and clinical validation of the cobas® Factor II and Factor V test John W. LongshoreKelli DeMartinSylwia Karwowska OriginalPaper Open access 03 October 2018 Pages: 87 - 95
Ruling out deep vein thrombosis in patients with superficial vein thrombosis: external validation of the ICARO score Paul FrappéQuentin BrosseSTEPH Study Group OriginalPaper 13 October 2018 Pages: 96 - 101
Knowledge, attitude, and practice of healthcare professionals toward clinically applying graduated compression stockings: results of a Chinese web-based survey Yaping XuWei WangTingting Zhao OriginalPaper Open access 06 October 2018 Pages: 102 - 108
Analyzing the impact of systems-based hematologist in the healthcare system at an academic medical center Ming Y. LimCharles S. Greenberg BriefCommunication 13 October 2018 Pages: 109 - 112
Intravenous thrombolysis for ischemic stroke in the Veneto region: the gap between eligibility and reality Stefano ForlivesiManuel CappellariPaolo Bovi OriginalPaper 05 October 2018 Pages: 113 - 120
Thrombosis, anticoagulation and outcomes in malignant superior vena cava syndrome Roy RatzonShlomit TamirAvi Leader OriginalPaper 25 September 2018 Pages: 121 - 128
Combined use of antifibrinolytics and activated prothrombin complex concentrate (aPCC) is not related to thromboembolic events in patients with acquired haemophilia A: data from FAIR Registry S. PascaC. Ambagliofor the FAIR Study Group BriefCommunication 28 September 2018 Pages: 129 - 133
Long-term follow-up of the stenting across the iliocaval confluence in patients with iliac venous lesions Xicheng ZhangYuanhu JingXiaoqiang Li OriginalPaper 16 October 2018 Pages: 134 - 139
Does proton pump inhibition change the on-treatment anti-Xa activity in xabans-treated patients with atrial fibrillation? A pilot study Tomáš BolekMatej SamošMarián Mokáň BriefCommunication 04 October 2018 Pages: 140 - 145
Direct oral anticoagulants: a review of common medication errors Drakeria BarrQuovadis J. Epps ReviewPaper 08 October 2018 Pages: 146 - 154
Increased risk of heparin induced thrombocytopenia and thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation Roberto CastelliPaolo GallipoliLuigi Bergamaschini Letter to the Editor 26 November 2018 Pages: 155 - 156
Coronary thrombosis in acute pancreatitis Saagar SanghviFahad WaqarMohamed Effat BriefCommunication 29 September 2018 Pages: 157 - 161
Acute cytomegalovirus infection associated with pulmonary embolism treated successfully with rivaroxaban: case report Clarissa Maria Gomes de AlmeidaFauze Camargo MalufCesar de Almeida-Neto Report 23 October 2018 Pages: 162 - 164
Correction to: New clotting disorders that cast new light on blood coagulation and may play a role in clinical practice A. GirolamiE. CosiB Girolami Correction 20 November 2018 Pages: 165 - 165
Correction to: Direct oral anticoagulants for the treatment of venous thromboembolism in patients with active malignancy: a systematic review and meta-analysis M. S. Al YamiA. McBrideI. Abraham Correction 26 November 2018 Pages: 166 - 166